These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 23124941)

  • 1. Fibrosis and heart failure.
    Segura AM; Frazier OH; Buja LM
    Heart Fail Rev; 2014 Mar; 19(2):173-85. PubMed ID: 23124941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac fibrosis as a cause of diastolic dysfunction.
    Burlew BS; Weber KT
    Herz; 2002 Mar; 27(2):92-8. PubMed ID: 12025467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue and the heart. Functional significance and regulatory mechanisms.
    Burlew BS; Weber KT
    Cardiol Clin; 2000 Aug; 18(3):435-42. PubMed ID: 10986582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myofibroblast-mediated mechanisms of pathological remodelling of the heart.
    Weber KT; Sun Y; Bhattacharya SK; Ahokas RA; Gerling IC
    Nat Rev Cardiol; 2013 Jan; 10(1):15-26. PubMed ID: 23207731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress.
    Kandalam V; Basu R; Moore L; Fan D; Wang X; Jaworski DM; Oudit GY; Kassiri Z
    Circulation; 2011 Nov; 124(19):2094-105. PubMed ID: 21986284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study.
    Fernandes F; Ramires FJ; Arteaga E; Ianni BM; Bonfá ES; Mady C
    J Card Fail; 2003 Aug; 9(4):311-7. PubMed ID: 13680552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate Loss of the Extracellular Matrix Proteoglycan Lumican Attenuates Cardiac Fibrosis in Mice Subjected to Pressure Overload.
    Mohammadzadeh N; Melleby AO; Palmero S; Sjaastad I; Chakravarti S; Engebretsen KVT; Christensen G; Lunde IG; Tønnessen T
    Cardiology; 2020; 145(3):187-198. PubMed ID: 31968347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: implications for heart failure in the elderly.
    Butler CR; Jugdutt BI
    Heart Fail Rev; 2012 Sep; 17(4-5):615-33. PubMed ID: 22258830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Extracellular Matrix in Ischemic and Nonischemic Heart Failure.
    Frangogiannis NG
    Circ Res; 2019 Jun; 125(1):117-146. PubMed ID: 31219741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action.
    Drakos SG; Kfoury AG; Selzman CH; Verma DR; Nanas JN; Li DY; Stehlik J
    Curr Opin Cardiol; 2011 May; 26(3):245-55. PubMed ID: 21451407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart.
    Stansfield WE; Andersen NM; Tang RH; Selzman CH
    Ann Thorac Surg; 2009 Dec; 88(6):1916-21. PubMed ID: 19932262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities.
    Frangogiannis NG
    Mol Aspects Med; 2019 Feb; 65():70-99. PubMed ID: 30056242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
    Klotz S; Naka Y; Oz MC; Burkhoff D
    J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Microfibrillar-Associated Protein 4 Attenuates Left Ventricular Remodeling and Dysfunction in Heart Failure.
    Wang HB; Yang J; Shuai W; Yang J; Liu LB; Xu M; Tang QZ
    J Am Heart Assoc; 2020 Sep; 9(17):e015307. PubMed ID: 32856514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular changes occurring during reverse remodelling following left ventricular assist device support.
    Birks EJ; George RS
    J Cardiovasc Transl Res; 2010 Dec; 3(6):635-42. PubMed ID: 20820974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of mechanical unloading on structural and nonstructural components of the extracellular matrix in advanced human heart failure.
    Sakamuri SS; Takawale A; Basu R; Fedak PW; Freed D; Sergi C; Oudit GY; Kassiri Z
    Transl Res; 2016 Jun; 172():30-44. PubMed ID: 26963743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction.
    Poulsen SH
    Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The response of the failing heart to chronic mechanical unloading.
    Wallace CK; Koerner MM; Thohan V; Loebe M; Lafuente J; Noon GP; Torre-Amione G
    Curr Opin Cardiol; 2004 May; 19(3):270-7. PubMed ID: 15096961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
    Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
    Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling.
    Kato TS; Chokshi A; Singh P; Khawaja T; Cheema F; Akashi H; Shahzad K; Iwata S; Homma S; Takayama H; Naka Y; Jorde U; Farr M; Mancini DM; Schulze PC
    Circ Heart Fail; 2011 Sep; 4(5):546-53. PubMed ID: 21765125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.